title: Evaluating the cost-effectiveness of cancer patient navigation programs: conceptual and practical issues.
abstract: Patient navigators-individuals who assist patients through the healthcare system to improve access to and understanding of their health and healthcare-are increasingly used for underserved individuals at risk for or with cancer. Navigation programs can improve access, but it is unclear whether they improve the efficiency and efficacy of cancer diagnostic and therapeutic services at a reasonable cost, such that they would be considered cost-effective. In the current study, the authors outline a conceptual model for evaluating the cost-effectiveness of cancer navigation programs. They describe how this model is being applied to the Patient Navigation Research Program, a multicenter study supported by the National Cancer Institute's Center to Reduce Cancer Health Disparities. The Patient Navigation Research Program is testing navigation interventions that aim to reduce time to delivery of quality cancer care (noncancer resolution or cancer diagnosis and treatment) after identification of a screening abnormality. Examples of challenges to evaluating cost-effectiveness of navigation programs include the heterogeneity of navigation programs, the sometimes distant relation between navigation programs and outcome of interest (eg, improving access to prompt diagnostic resolution and life-years gained), and accounting for factors in underserved populations that may influence both access to services and outcomes. In this article, the authors discuss several strategies for addressing these barriers. Evaluating the costs and impact of navigation will require some novel methods, but will be critical in recommendations concerning dissemination of navigation programs.
authors.affiliation: Cancer Technology Assessment Group, Translational and Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA. sramsey@fhcrc.org
authors.forename: Scott
authors.initials: S
authors.lastname: Ramsey
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Whitley
authors.forename: Victoria Warren
authors.initials: VW
authors.lastname: Mears
authors.forename: June M
authors.initials: JM
authors.lastname: McKoy
authors.forename: Rachel M
authors.initials: RM
authors.lastname: Everhart
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Caswell
authors.forename: Kevin
authors.initials: K
authors.lastname: Fiscella
authors.forename: Thelma C
authors.initials: TC
authors.lastname: Hurd
authors.forename: Tracy
authors.initials: T
authors.lastname: Battaglia
authors.forename: Jeanne
authors.initials: J
authors.lastname: Mandelblatt
mesh_terms: D003362:Cost-Benefit Analysis; D006078:Government Programs; D006297:Health Services Accessibility / Q000191:economics* / Q000458:organization & administration*; D054625:Healthcare Disparities; D006801:Humans; D009369:Neoplasms / Q000191:economics* / Q000628:therapy*; D015397:Program Evaluation
references.citation: Cancer. 2003 Jan 1;97(1):134-47
references.pmid: 12491515
references.citation: J Clin Oncol. 2008 Apr 1;26(10):1684-90
references.pmid: 18375897
references.citation: Cancer. 2008 Dec 15;113(12):3391-9
references.pmid: 18951521
references.citation: Surg Oncol Clin N Am. 2005 Oct;14(4):655-69, v
references.pmid: 16226685
references.citation: J Natl Cancer Inst. 1999 Oct 6;91(19):1641-6
references.pmid: 10511591
references.citation: Pharmacoeconomics. 1998 Mar;13(3):277-88
references.pmid: 10178653
references.citation: J Clin Oncol. 2000 Sep 15;18(18):3302-17
references.pmid: 10986064
references.citation: Cancer. 2006 Mar 15;106(6):1276-85
references.pmid: 16475208
references.citation: Ethn Dis. 2002 Winter;12(1):77-86
references.pmid: 11913611
references.citation: J Clin Oncol. 2006 Mar 20;24(9):1357-62
references.pmid: 16549830
references.citation: Cancer. 1989 Jun 15;63(12):2562-9
references.pmid: 2720605
references.citation: J Natl Cancer Inst. 2007 Jan 3;99(1):14-23
references.pmid: 17202109
references.citation: Cancer. 2004 Apr 15;100(8):1595-604
references.pmid: 15073845
references.citation: Cancer. 2008 Oct 15;113(8):1999-2010
references.pmid: 18780320
references.citation: J Urban Health. 2008 Jan;85(1):114-24
references.pmid: 17906931
references.citation: JAMA. 1996 Oct 9;276(14):1172-7
references.pmid: 8827972
references.citation: Am J Gastroenterol. 2003 Sep;98(9):2078-81
references.pmid: 14499791
references.citation: Am J Public Health. 1997 Jul;87(7):1182-9
references.pmid: 9240110
references.citation: Breast Cancer Res Treat. 2003 Sep;81(1):21-31
references.pmid: 14531494
references.citation: J Am Coll Surg. 2003 Feb;196(2):180-8
references.pmid: 12595043
references.citation: Pharmacoeconomics. 2000 May;17(5):479-500
references.pmid: 10977389
references.citation: J Cancer Educ. 2006 Spring;21(1 Suppl):S11-4
references.pmid: 17020496
references.citation: Med Care. 2008 Apr;46(4):349-56
references.pmid: 18362813
references.citation: Prev Med. 2007 Jan;44(1):26-33
references.pmid: 16962652
references.citation: J Cancer Educ. 1998 Winter;13(4):213-9
references.pmid: 9883780
references.citation: Cancer. 2007 Jan 15;109(2 Suppl):359-67
references.pmid: 17123275
references.citation: Cancer. 2005 Aug 15;104(4):848-55
references.pmid: 16010658
references.citation: Expert Rev Pharmacoecon Outcomes Res. 2003 Oct;3(5):561-7
references.pmid: 19807390
references.citation: J Natl Cancer Inst. 2008 May 7;100(9):630-41
references.pmid: 18445825
references.citation: J Clin Oncol. 2003 Mar 15;21(6):1139-46
references.pmid: 12637482
references.citation: J Gen Intern Med. 1997 Sep;12(9):551-8
references.pmid: 9294789
references.citation: CA Cancer J Clin. 2004 Mar-Apr;54(2):78-93
references.pmid: 15061598
references.citation: Cancer Pract. 1995 Jan-Feb;3(1):19-30
references.pmid: 7704057
references.citation: J Natl Med Assoc. 2008 Mar;100(3):278-84
references.pmid: 18390020
references.citation: JAMA. 1996 Oct 16;276(15):1253-8
references.pmid: 8849754
references.citation: Health Policy. 1990 Dec;16(3):199-208
references.pmid: 10109801
references.citation: Can Assoc Radiol J. 2004 Jun;55(3):145-50
references.pmid: 15237774